Home / Resource Library / Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice

Circulating tumour DNA as a predictor of survival of patients with diffuse large B-cell lymphoma in a daily practice

Article discusses the use of circulating tumour DNA as a biomarker in clinical practice